These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Ther Drug Monit; 2019 Jun; 41(3):261-307. PubMed ID: 31045868 [Abstract] [Full Text] [Related]
13. Evidence of different pharmacokinetics between cyclosporine and tacrolimus in renal transplant recipients: why cyclosporine is monitored by C2 level and tacrolimus by trough level. Takeuchi H, Matsuno N, Hirano T, Toraishi T, Konno O, Nakamura Y, Iwamoto H, Hama K, Unezaki S, Nagao T. Transplant Proc; 2008 Sep; 40(7):2240-2. PubMed ID: 18790203 [Abstract] [Full Text] [Related]
14. Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure. Saint-Marcoux F, Woillard JB, Jurado C, Marquet P. Ther Drug Monit; 2013 Jun; 35(3):322-7. PubMed ID: 23666572 [Abstract] [Full Text] [Related]
15. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Staatz CE, Tett SE. Clin Pharmacokinet; 2004 Jun; 43(10):623-53. PubMed ID: 15244495 [Abstract] [Full Text] [Related]
16. A pharmacodynamic investigation of tacrolimus in pediatric liver transplantation. Staatz CE, Taylor PJ, Lynch SV, Tett SE. Liver Transpl; 2004 Apr; 10(4):506-12. PubMed ID: 15048793 [Abstract] [Full Text] [Related]
17. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients. Lemaitre F, Antignac M, Fernandez C. Clin Biochem; 2013 Oct; 46(15):1538-41. PubMed ID: 23454394 [Abstract] [Full Text] [Related]
18. Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients. Dansirikul C, Staatz CE, Duffull SB, Taylor PJ, Lynch SV, Tett SE. J Clin Pharm Ther; 2006 Feb; 31(1):17-25. PubMed ID: 16476116 [Abstract] [Full Text] [Related]
19. Evaluation of limited sampling strategies for tacrolimus. Op den Buijsch RA, van de Plas A, Stolk LM, Christiaans MH, van Hooff JP, Undre NA, van Dieijen-Visser MP, Bekers O. Eur J Clin Pharmacol; 2007 Nov; 63(11):1039-44. PubMed ID: 17712551 [Abstract] [Full Text] [Related]
20. Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. Andrews LM, Li Y, De Winter BCM, Shi YY, Baan CC, Van Gelder T, Hesselink DA. Expert Opin Drug Metab Toxicol; 2017 Dec; 13(12):1225-1236. PubMed ID: 29084469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]